Can meta-analysis suggest carboplatin/paclitaxel as a reference arm in randomized trials of first-line chemotherapy for advanced non-small cell lung cancer?

被引：0
|
作者：
Yamanaka, T.
Yamamoto, N.
Seto, T.
Takahashi, T.
Murakami, H.
Tsuya, A.
Naito, T.
Kaira, K.
Nakamura, Y.
Ichinose, Y.
机构：
[1] Kyushu Natl Canc Ctr, Fukuoka, Japan
[2] Shizuoka Canc Ctr, Shizuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19039
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Lim, Kyu-Hyoung
    Lee, Hui-Young
    Song, Seo-Young
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4644 - 4648
  • [22] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Kyu-Hyoung Lim
    Hui-Young Lee
    Seo-Young Song
    中华医学杂志(英文版), 2013, 126 (24) : 4644 - 4648
  • [23] The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis
    Yaxiong Zhang
    Wenfeng Fang
    Yue Yan
    Mengyao Wang
    Shiyang Kang
    Jin Sheng
    Jianhua Zhan
    Nan Chen
    Shaodong Hong
    Yunpeng Yang
    Yuxiang Ma
    Dacheng He
    Tao Qin
    Ting Zhou
    Yanna Tang
    Xiaobo He
    Wenhua Liang
    Li Zhang
    Medical Oncology, 2015, 32
  • [24] The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis
    Zhang, Yaxiong
    Fang, Wenfeng
    Yan, Yue
    Wang, Mengyao
    Kang, Shiyang
    Sheng, Jin
    Zhan, Jianhua
    Chen, Nan
    Hong, Shaodong
    Yang, Yunpeng
    Ma, Yuxiang
    He, Dacheng
    Qin, Tao
    Zhou, Ting
    Tang, Yanna
    He, Xiaobo
    Liang, Wenhua
    Zhang, Li
    MEDICAL ONCOLOGY, 2015, 32 (03)
  • [25] A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer
    Jiang, Jingwei
    Liang, Xiaohua
    Zhou, Xinli
    Huang, Ruofan
    Chu, Zhaohui
    LUNG CANCER, 2007, 57 (03) : 348 - 358
  • [26] Triplet chemotherapy with paclitaxel, gemcitabine and carboplatin in advanced non-small cell lung cancer
    Bunn, PA
    Kelly, K
    Mikhaeel, N
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 21 - 21
  • [27] Docetaxel in combination with cisplatin for first-line treatment of locally advanced or metastasic non-small cell lung cancer:: meta-analysis of randomized and controlled clinical trials
    Lerma, BS
    Sánchez, IP
    Grima, FG
    MEDICINA CLINICA, 2004, 122 (08): : 281 - 287
  • [28] Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: A meta-analysis of seven randomized clinical trials
    Douillard, Jean-Yves
    Laporte, Silvy
    Fossella, Frank
    Georgoulias, Vassilis
    Pujol, Jean-Louis
    Kubota, Kaoru
    Monnier, Alain
    Kudoh, Shinzoh
    Rubio, Jaime Ernesto
    Cucherat, Michel
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (10) : 939 - 946
  • [29] Randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line chemotherapy in advanced non-small cell lung cancer.
    Nagel, S.
    Groeschel, A.
    Sebastian, M.
    Andreas, S.
    Mueller, T.
    Schneller, F.
    Guetz, S.
    Leschinger, M. I.
    Buettner, H.
    Reck, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Gefitinib Compared with Systemic Chemotherapy as First-line Treatment for Chemotherapy-naive Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of Randomised Controlled Trials
    Wang, F.
    Wang, L. D.
    Li, B.
    Sheng, Z. X.
    CLINICAL ONCOLOGY, 2012, 24 (06) : 396 - 401
12345